Literature DB >> 30890880

Cell adhesion molecules in Alzheimer's disease.

Malin Wennström1, Henrietta M Nielsen1.   

Abstract

Cell adhesion molecules (CAMs) mediate interactions between cells and their surroundings that are vital to processes controlling for cell survival, activation, migration, and plasticity. However, increasing evidence suggests that CAMs also mediate mechanisms involved in several neurological diseases. This article reviews the current knowledge on the role of CAMs in amyloid-β (Aβ) metabolism, cell plasticity, neuroinflammation, and vascular changes, all of which are considered central to the pathogenesis and progression of Alzheimer's disease (AD). This paper also outlines the possible roles of CAMs in current and novel AD treatment strategies.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-beta; cell adhesion molecules; neuroinflammation; plasticity; vascular changes

Year:  2012        PMID: 30890880      PMCID: PMC6065556          DOI: 10.2147/DNND.S19829

Source DB:  PubMed          Journal:  Degener Neurol Neuromuscul Dis        ISSN: 1179-9900


  8 in total

1.  PTPRD and DCC Are Novel BACE1 Substrates Differentially Expressed in Alzheimer's Disease: A Data Mining and Bioinformatics Study.

Authors:  Hannah A Taylor; Katie J Simmons; Eva M Clavane; Christopher J Trevelyan; Jane M Brown; Lena Przemyłska; Nicole T Watt; Laura C Matthews; Paul J Meakin
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

2.  Association of microbiota-derived propionic acid and Alzheimer's disease; bioinformatics analysis.

Authors:  Morteza Aliashrafi; Mohammad Nasehi; Mohammad-Reza Zarrindast; Mohammad Taghi Joghataei; Hakimeh Zali; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2020-06-23

3.  CaSR Antagonist (Calcilytic) NPS 2143 Hinders the Release of Neuroinflammatory IL-6, Soluble ICAM-1, RANTES, and MCP-2 from Aβ-Exposed Human Cortical Astrocytes.

Authors:  Anna Chiarini; Ubaldo Armato; Peng Hu; Ilaria Dal Prà
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

Review 4.  Drugs Modulating CD4+ T Cells Blood-Brain Barrier Interaction in Alzheimer's Disease.

Authors:  Norwin Kubick; Patrick C Henckell Flournoy; Ana-Maria Enciu; Gina Manda; Michel-Edwar Mickael
Journal:  Pharmaceutics       Date:  2020-09-16       Impact factor: 6.321

5.  Sex-specific DNA methylation differences in Alzheimer's disease pathology.

Authors:  Lanyu Zhang; Juan I Young; Lissette Gomez; Tiago C Silva; Michael A Schmidt; Jesse Cai; Xi Chen; Eden R Martin; Lily Wang
Journal:  Acta Neuropathol Commun       Date:  2021-04-26       Impact factor: 7.801

Review 6.  Biochemical Pathways of Cellular Mechanosensing/Mechanotransduction and Their Role in Neurodegenerative Diseases Pathogenesis.

Authors:  Ilaria Tortorella; Chiara Argentati; Carla Emiliani; Francesco Morena; Sabata Martino
Journal:  Cells       Date:  2022-10-01       Impact factor: 7.666

Review 7.  MicroRNA: A Key Player for the Interplay of Circadian Rhythm Abnormalities, Sleep Disorders and Neurodegenerative Diseases.

Authors:  Chisato Kinoshita; Yayoi Okamoto; Koji Aoyama; Toshio Nakaki
Journal:  Clocks Sleep       Date:  2020-07-23

8.  Comparative Phosphoproteomics of Neuro-2a Cells under Insulin Resistance Reveals New Molecular Signatures of Alzheimer's Disease.

Authors:  Dayea Kim; Yeon Suk Jo; Han-Seul Jo; Sungwon Bae; Yang Woo Kwon; Yong-Seok Oh; Jong Hyuk Yoon
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.